Inspire Medical Systems, Inc.

Historical 13F Holders

Symbol
INSP
CUSIP
457730109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 457730109 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 14.4% 7/28/2026
Event 6/30/2026
Wellington Management Group LLP 13G/A
8.8% 5/15/2026
Event 3/31/2026
Vanguard Portfolio Management LLC 13G/A 7.4% 7/31/2026
Event 6/30/2026
Soleus Capital Master Fund, L.P. 13G/A
6.7% 8/13/2026
Event 6/30/2026
AQR Capital Management, LLC 13G
6.4% 8/12/2026
Event 6/30/2026
D. E. Shaw & Co., L.P. 13G
5.1% 7/2/2026
Event 6/25/2026
Vanguard Capital Management LLC 13G 5.1% 4/30/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
James E. Flynn 13G/A
4.5% 5/14/2026
Event 5/14/2026
FMR LLC 13G/A
2.5% 10/7/2025
Event 9/30/2025
Citadel Advisors LLC 13G/A
1.8% 2/17/2026
Event 12/31/2025
Wasatch Advisors LP 13G/A 0.5% 11/12/2025
Event 9/30/2025
Dragoneer Investment Group, LLC 13G/A
0% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 10 6.67 k $462 k
2026 Q2 288 39.5 M $1.73 B
2026 Q1 318 34.9 M $1.80 B
2025 Q4 374 34.6 M $3.19 B
2025 Q3 345 31.2 M $2.32 B
2025 Q2 381 33.8 M $4.39 B
2025 Q1 392 34.4 M $5.51 B
2024 Q4 390 33.4 M $6.20 B
2024 Q3 388 34.1 M $7.20 B
2024 Q2 364 32.7 M $4.38 B
2024 Q1 367 32.7 M $7.03 B
2023 Q4 383 31.9 M $6.48 B
2023 Q3 399 28.6 M $5.68 B
2023 Q2 442 28.5 M $9.26 B
2023 Q1 400 29.3 M $6.80 B
2022 Q4 367 29.4 M $7.39 B
2022 Q3 332 28.3 M $5.02 B
2022 Q2 308 27.4 M $5.01 B
2022 Q1 319 27.0 M $6.92 B
2021 Q4 318 25.9 M $5.96 B
2021 Q3 271 25.4 M $5.92 B
2021 Q2 267 25.0 M $4.83 B
2021 Q1 269 25.2 M $5.21 B
2020 Q4 258 25.2 M $4.73 B
2020 Q3 226 26.2 M $3.38 B
2020 Q2 204 26.9 M $2.35 B
2020 Q1 183 23.9 M $1.44 B
2019 Q4 185 22.4 M $1.66 B
2019 Q3 168 21.8 M $1.33 B
2019 Q2 166 20.2 M $1.23 B
2019 Q1 153 17.8 M $1.01 B
2018 Q4 107 15.0 M $634 M
2018 Q3 91 9.33 M $393 M
2018 Q2 77 9.47 M $338 M